Saint-Criq V et al. |
Restoration of chloride efflux by azithromycin in airway epithelial cells of cystic fibrosis patients. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21220528
|
Sato T et al. |
In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21220530
|
Lu Y et al. |
Antibiotics Promote Escherichia coli-Pseudomonas aeruginosa Conjugation through Inhibiting Quorum Sensing. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28993333
|
Nilius AM et al. |
Comparative in vitro activity of ABT-773, a novel antibacterial ketolide. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11408246
|
Parry CM et al. |
Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17145784
|
Peric M et al. |
Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12604536
|
Seral C et al. |
Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12604540
|
Roblin PM et al. |
In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12604555
|
Donowitz GR and Earnhardt KI |
Azithromycin inhibition of intracellular Legionella micdadei. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285604
|
Ishida K et al. |
In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031048
|
Hauser C et al. |
In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25547354
|
Solomon AW et al. |
Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16251338
|
Bermudez LE et al. |
Stimulation with cytokines enhances penetration of azithromycin into human macrophages. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1667256
|
Koeva M et al. |
An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923873
|
Saiz JC and MartÃn-Acebes MA |
Reply to Iannetta et al., "Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells". |
2017 |
Antimicrob. Agents Chemother. |
pmid:28839084
|
Iannetta M et al. |
Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28839081
|
Ohrt C et al. |
Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12121927
|
Dubois J et al. |
In vitro and intracellular activities of peptide deformylase inhibitor GSK1322322 against Legionella pneumophila isolates. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25348534
|
Feola DJ et al. |
Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20231397
|
Riska PF et al. |
Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15328134
|
Watt G et al. |
Azithromycin activities against Orientia tsutsugamushi strains isolated in cases of scrub typhus in Northern Thailand. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543774
|
Maezono H et al. |
Antibiofilm effects of azithromycin and erythromycin on Porphyromonas gingivalis. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21911560
|
Kutlin A et al. |
In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10471577
|
Bui KQ et al. |
Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10471584
|
Zarantonelli L et al. |
Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10508026
|
Yamada K et al. |
Azithromycin attenuates lung inflammation in a mouse model of ventilator-associated pneumonia by multidrug-resistant Acinetobacter baumannii. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23733468
|
Pandori MW et al. |
Detection of azithromycin resistance in Treponema pallidum by real-time PCR. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17620374
|
Hoffmann N et al. |
Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17620382
|
Moon JE et al. |
Efficacy of macrolides and telithromycin against leptospirosis in a hamster model. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16723556
|
Bogdanovich T et al. |
Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16723565
|
Kosowska-Shick K et al. |
Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16723567
|
Zhanel GG et al. |
Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16723591
|
Carannante A et al. |
Changing antimicrobial resistance profiles among Neisseria gonorrhoeae isolates in Italy, 2003 to 2012. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25070110
|
Wierzbowski AK et al. |
Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16251306
|
Jesus FP et al. |
In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25001300
|
Zhang Y et al. |
Novel Detection Strategy To Rapidly Evaluate the Efficacy of Antichlamydial Agents. |
2017 |
Antimicrob. Agents Chemother. |
pmid:27855081
|
Miura Y et al. |
Maternal intravenous treatment with either azithromycin or solithromycin clears Ureaplasma parvum from the amniotic fluid in an ovine model of intrauterine infection. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24982089
|
Kohlhoff SA et al. |
In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15105151
|
Waites KB et al. |
In Vitro Activities of Lefamulin and Other Antimicrobial Agents against Macrolide-Susceptible and Macrolide-Resistant Mycoplasma pneumoniae from the United States, Europe, and China. |
2017 |
Antimicrob. Agents Chemother. |
pmid:27855075
|
Brieland JK et al. |
Efficacy of SCH27899 in an animal model of Legionnaires' disease using immunocompromised A/J mice. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10770771
|
Luke DR et al. |
Safety, toleration, and pharmacokinetics of intravenous azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913468
|
Waites KB et al. |
In Vitro Activities of Omadacycline (PTK 0796) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27671057
|
Scorneaux B et al. |
Effect of recombinant human gamma interferon on intracellular activities of antibiotics against Listeria monocytogenes in the human macrophage cell line THP-1. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8723471
|
Olsen KM et al. |
Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913469
|
Hogan PA and Sheehan DJ |
Macrolide susceptibility and beta-lactamase production among haemophilus influenzae isolates in the United States, 1996-1997. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9835536
|
Shimuta K et al. |
Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23939890
|
D'Ignazio J et al. |
Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired Pneumonia in adults. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16189077
|
Gillis RJ et al. |
Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16127063
|
Jensen JS et al. |
In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24637681
|
RÃos AM et al. |
Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16127085
|
Bermudez LE et al. |
Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11120969
|
Bielaszewska M et al. |
Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22391549
|
Berry V et al. |
Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzae. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15728883
|
GarcÃa-Quintanilla M et al. |
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27270288
|
Fuentes F et al. |
Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527796
|
Kashuba AD and Amsden GW |
Bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527816
|
Noedl H et al. |
In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17116669
|
Nagai K et al. |
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600391
|
Beale AS and Upshon PA |
Characteristics of murine model of genital infection with Chlamydia trachomatis and effects of therapy with tetracyclines, amoxicillin-clavulanic acid, or azithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7811001
|
Pruul H and McDonald PJ |
Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1317141
|
Yeruva L et al. |
Differential susceptibilities to azithromycin treatment of chlamydial infection in the gastrointestinal tract and cervix. |
2013 |
Antimicrob. Agents Chemother. |
pmid:24100498
|
Brown BA et al. |
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1317144
|
Spangler SK et al. |
Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192445
|
Niki Y et al. |
In vitro and in vivo activities of azithromycin, a new azalide antibiotic, against chlamydia. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7840560
|
Welsh LE et al. |
In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1318677
|
Stamler DA et al. |
Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192446
|
Freeman CD et al. |
Intracellular and extracellular penetration of azithromycin into inflammatory and noninflammatory blister fluid. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7840585
|
Caronzolo D et al. |
Effect of PEX, a noncatalytic metalloproteinase fragment with integrin-binding activity, on experimental Chlamydophila pneumoniae infection. |
2006 |
Antimicrob. Agents Chemother. |
pmid:17005805
|
Reveneau N et al. |
Bactericidal activity of first-choice antibiotics against gamma interferon-induced persistent infection of human epithelial cells by Chlamydia trachomatis. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15855497
|
Mizukane R et al. |
Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8203850
|
Taylor WR et al. |
Tolerability of azithromycin as malaria prophylaxis in adults in northeast papua, indonesia. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12821468
|
Seral C et al. |
Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12821480
|
Perronne C et al. |
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1656860
|
Araujo FG and Remington JS |
Synergistic activity of azithromycin and gamma interferon in murine toxoplasmosis. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1656872
|
Taylor DE and Chang N |
In vitro susceptibilities of Campylobacter jejuni and Campylobacter coli to azithromycin and erythromycin. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1659309
|
Goldstein EJ et al. |
Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7625795
|
Ressner RA et al. |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18411316
|
Wingard JB et al. |
A novel cell-associated protection assay demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21628536
|
Plouffe J et al. |
Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858333
|
Skindersoe ME et al. |
Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18644954
|
Su XH et al. |
Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914). |
2015 |
Antimicrob. Agents Chemother. |
pmid:26482313
|
Jesus FP et al. |
In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26459895
|
Pfefferkorn ER and Borotz SE |
Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8141576
|
Rakita RM et al. |
Intracellular activity of azithromycin against bacterial enteric pathogens. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7810998
|
Pankuch GA et al. |
In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniae. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9797225
|
Wind CM et al. |
A Case-Control Study of Molecular Epidemiology in Relation to Azithromycin Resistance in Neisseria gonorrhoeae Isolates Collected in Amsterdam, the Netherlands, between 2008 and 2015. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28373191
|
Salman S et al. |
Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic Modeling. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28242669
|
Unemo M et al. |
High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26077246
|
Pereira MR et al. |
In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21464242
|
Bogdanovich T et al. |
Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16495248
|
Lai PC and Walters JD |
Azithromycin kills invasive Aggregatibacter actinomycetemcomitans in gingival epithelial cells. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23274657
|
Sjölund Karlsson M et al. |
Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23274665
|
Odenholt I et al. |
Studies of the killing kinetics of benzylpenicillin, cefuroxime, azithromycin, and sparfloxacin on bacteria in the postantibiotic phase. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9371360
|
Gnarpe J et al. |
In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843291
|
Dreses-Werringloer U et al. |
Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600348
|
Garey KW et al. |
Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223928
|
Ouadrhiri Y et al. |
Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223943
|
Könönen E et al. |
beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223950
|
Soares GM et al. |
Effects of azithromycin, metronidazole, amoxicillin, and metronidazole plus amoxicillin on an in vitro polymicrobial subgingival biofilm model. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25733510
|
Parry CM et al. |
Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25733500
|